Myriad Genetics: Q4 Earnings Insights

Myriad Genetics MYGN reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Myriad Genetics beat estimated earnings by 300.0%, reporting an EPS of $0.04 versus an estimate of $0.01.

Revenue was up $18.80 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 9.0% increase in the share price the next day.

Here's a look at Myriad Genetics's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.08 -0.08 -0.19 -0.16
EPS Actual -0.03 -0.08 -0.21 -0.12
Revenue Estimate 179.25M 187.13M 171.55M 169.46M
Revenue Actual 191.90M 183.50M 181.20M 177.80M

To track all earnings releases for Myriad Genetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!